Private Capital Group, LLC Neurocrine Biosciences Inc Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Private Capital Group, LLC holds 384 shares of NBIX stock, worth $48,249. This represents 0.03% of its overall portfolio holdings.

Number of Shares

384

Previous 701 45.22%

Holding current value

$48,249

Previous $66,000 43.94%

% of portfolio

0.03%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$75.79 - $100.07 $24,025 - $31,722	-317 Reduced 45.22%	384 $37,000
Q1 2022 Apr 21, 2022	BUY	$72.45 - $94.81 $18,619 - $24,366	257 Added 57.88%	701 $66,000
Q4 2021 Jan 24, 2022	SELL	$79.65 - $106.22 $12,664 - $16,888	-159 Reduced 26.37%	444 $38,000
Q3 2021 Oct 13, 2021	BUY	$86.18 - $99.03 $25,767 - $29,609	299 Added 98.36%	603 $58,000
Q2 2021 Jul 26, 2021	SELL	$89.43 - $102.27 $5,276 - $6,033	-59 Reduced 16.25%	304 $30,000
Q1 2021 Apr 12, 2021	SELL	$87.57 - $119.4 $5,867 - $7,999	-67 Reduced 15.58%	363 $35,000
Q4 2020 Jan 26, 2021	SELL	$86.91 - $108.33 $10,342 - $12,891	-119 Reduced 21.68%	430 $41,000
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $20,289 - $28,516	211 Added 62.43%	549 $53,000
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $2,042 - $3,128	24 Added 7.64%	338 $41,000
Q1 2020 May 07, 2020	BUY	$75.11 - $113.76 $4,581 - $6,939	61 Added 24.11%	314 $27,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $4,774 - $6,521	55 Added 27.78%	253 $27,000
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $13,495 - $16,341	161 Added 435.14%	198 $18,000
Q2 2019 Aug 15, 2019	SELL	$72.24 - $91.27 $11,991 - $15,150	-166 Reduced 81.77%	37 $4,000
Q1 2019 Apr 26, 2019	BUY	$69.31 - $91.53 $14,069 - $18,580	203 New	203 $18,000
Q3 2018 Oct 31, 2018	SELL	$98.88 - $125.85 $3,658 - $4,656	-37 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$75.88 - $92.43 $16,541 - $20,149	-218 Reduced 85.49%	37 $3,000
Q4 2017 May 18, 2018	BUY	$58.53 - $77.59 $11,647 - $15,440	199 Added 355.36%	255 $8,000
Q4 2017 Mar 07, 2018	BUY	$58.53 - $77.59 $3,277 - $4,345	56	56 $1,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Neurocrine Biosciences Inc Transaction History